Big 3 Marijuana Stocks Steer Off a Cliff: Which Will Climb Out 1st?

With cannabis stocks taking a beating recently, investors have been wondering which one will recover first. Canopy, Aurora, and Aphria are all legitimate candidates.

If you have ever thought about investing in cannabis stocks, then you must have come across the big three marijuana companies: Canopy Growth, Aurora Cannabis, and Aphria (TSX:APHA)(NYSE:APHA).

However, all these companies have experienced a downturn in share price since October 25. That is not to say that you should no longer invest in cannabis stocks. In fact, this may be the ultimate opportunity to buy the best one during the dip. The only question to ask yourself is, which one shows the most promise? To answer that, though, you have to look at each company in detail.

Canopy Growth

The largest cannabis company by market capitalization got a massive boost through an investment from Constellation Brands worth $5 billion for about 38% ownership. Unfortunately, the investment has still not borne fruit, since Canopy Growth stock is down almost 60% from a high of $72 earlier in the year.

Constellation’s investment has allowed Canopy to focus on expansion in Europe of companies such as Acreage Holdings, Beckley Canopy Therapeutics and a majority stake in BioSteel Sports Nutrition.

While global acquisitions put Canopy’s standing in a superior position against its competitors, it has resulted in major quarterly losses, which is likely to continue. Unless it can start to turn these investments into actual returns soon, investors will start to get anxious and lead to short-term losses in share price.

Aurora Cannabis

As the largest cannabis producer in Canada, Aurora has probably not given you much to admire, dropping about 65% of its share value in the past six months. Unfortunately, it is Aurora’s very high supply that is causing problems for it, because there is simply too much marijuana. Worse still, the company is still spending money on the construction of greenhouses and farms.

This has forced the company to sell its marijuana at wholesale prices while still making a loss and up to $3.17 billion in goodwill. To make up for these near-term losses, Aurora intends to invest in international markets, but this means waiting for the profits to be realized.

Aphria

Unlike its competitors, Aphria has actually managed to turn a profit for two consecutive quarters. Many companies in the industry are making losses, and markets expected the company to report a net loss of $0.02 per share. Instead, a profit of $0.07 per share was reported in the first quarter of fiscal 2020, equivalent to $16.4 million in net profit. Revenue was also up from $13.3 million to $126.1 million year on year, although this was not surprising, considering marijuana was only recently legalized in Canada.

These results were great, but only for a moment, leading to a slight jump in stock prices up to $7.15 before dropping down to $6.73 at the time of writing. Furthermore, the revenue was lower than market expectations of $131 million. Investors became suspicious of their financial reports, taking note of $17.9 million earned in fair-value adjustments, without which the company would have made a loss. The company’s fiscal 2020 outlook was also very aggressive and would need to raise quarterly revenue up to $100 million for the next three quarters just to achieve its goals.

Which one has the highest likelihood of recovery?

Both Canopy and Aurora have invested heavily in international markets, hoping to gain from these markets and offset losses in local markets. This is a great strategy for a long-term investment, but Aurora remains to be the more popular choice. Meanwhile, Aphria investors are getting wary of the company’s financials, which should further improve Aurora stock price on the breakout.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jason Hoang has no position in any of the stocks mentioned.

More on Investing

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

A train passes Morant's curve in Banff National Park in the Canadian Rockies.
Investing

Is Canadian National Railway Worth Buying for its 2.2% Dividend Yield?

Let's dive into whether Canadian National Railway (TSX:CNR) is a top buy for long-term investors at this point in the…

Read more »

nuclear power plant
Energy Stocks

Is Cameco Stock Still a Buy?

Cameco stock recently reported earnings that showed the Westinghouse investment is creating some major costs. But that could change.

Read more »

cloud computing
Dividend Stocks

Insurance Showdown: Better Buy, Great-West Life or Manulife Stock?

GWO stock and MFC stock are two of the top names in insurance, but which holds the better outlook?

Read more »

analyze data
Dividend Stocks

Here’s Why the Average TFSA for Canadians Aged 41 Isn’t Enough

The average TFSA simply isn't enough for most Canadians in their early 40s. Here's how to catch up.

Read more »

A plant grows from coins.
Dividend Stocks

The Smartest Dividend-Growth Stocks to Buy With $1,000 Right Now

New dividend-growth investors should consider CN Rail (TSX:CNR) stock and another top play if they're looking to build wealth over…

Read more »

concept of real estate evaluation
Dividend Stocks

How to Earn a TFSA Paycheque Every Month and Pay No Taxes on It

Canadian REITs can turn your TFSA into a monthly paycheque machine for life. Here's how Morguard North American Residential REIT…

Read more »

Start line on the highway
Investing

2 No-Brainer Growth Stocks to Buy Now With $5,000 and Hold Long Term

Market conditions today are ideal for growth investing, and two rising stocks are no-brainer buys in November.

Read more »